Phase 3 Data Favor Bimekizumab Over Placebo in Biologic-Naïve Patients With Psoriatic ArthritisDecember 20th 2022
All primary and ranked secondary endpoints of the study were met at week 16, which were sustained or improved through week 24 and were coupled with patient-reported improvements compared with placebo in treating psoriatic arthritis.
Widespread Implementation of Long-Acting PrEP for HIV May Be Stifled By High Price Tag, Say ResearchersDecember 12th 2022
Following the approval of cabotegravir in 2021, governments and donor agencies in low- and middle-income countries are contemplating replacing oral pre-exposure prophylaxis or augmenting the approach with long-acting treatment.
Walgreens, Greater Than AIDS to Partner with Health Organizations to Offer Free HIV TestingJune 13th 2018
On National HIV Testing Day, which takes place on June 27, Walgreens and Greater Than AIDS will team up with over 200 health and community organizations to provide free HIV testing and information at Walgreens stores in over 180 cities.
Rucaparib May Potentially Benefit Patients with Advanced Pancreatic CancerMay 23rd 2018
Rucaparib, an (ADP-ribose) polymerase (PARP) inhibitor approved for the treatment of ovarian cancer, may have potential clinical benefit for patients with advanced pancreatic cancer and a BRCA1/2 mutation.